Publications on Doxoves®

Publications on Doxoves® (liposomal doxorubicin HCl through 03/17/2020)

Proton Pump Inhibitors Modulate Transport Of Doxorubicin And Its Liposomal Form Into 2D And 3D Breast Cancer Cell Cultures

Miglė Paškevičiūtė, Vilma Petrikaitė

Cancer Manag Res. 2019; 11: 9761–9769. Published online 2019 Nov 21. doi: 10.2147/CMAR.S224097

Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells

Muhammad Saad Khan, Jangsun Hwang, Kyungwoo Lee, Yonghyun Choi, Youngmin Seo, Hojeong Jeon, Jong Wook Hong, Jonghoon Choi

Cancers (Basel) 2019 Oct; 11(10): 1464. Published online 2019 Sep 29. doi: 10.3390/cancers11101464

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy

Megumi Kai, Arturas Ziemys, Yan ting Liu, Milos Kojic, Mauro Ferrari, Kenji Yokoi

Transl Oncol. 2019 Sep; 12(9): 1196–1205. Published online 2019 Jun 20. doi: 10.1016/j.tranon.2019.05.011

Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis

Xiaolan Qiu, Zhi Li, Xuedong Han, Linlin Zhen, Chao Luo, Minmin Liu, Kun Yu, Yi Ren

Theranostics. 2019; 9(9): 2618–2636. Published online 2019 Apr 13. doi: 10.7150/thno.32363

Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy

Suresh Ambati, Aileen R. Ferarro, S. Earl Khang, Jianfeng Lin, Xiaorong Lin, Michelle Momany, Zachary A. Lewis, Richard B. Meagher

mSphere. 2019 Jan-Feb; 4(1): e00025-19. Published online 2019 Feb 13. doi: 10.1128/mSphere.00025-19

Quantitative Imaging of Tumor Associated Macrophages and Their Response to Therapy Using ⁶⁴Cu-Labeled Macrin

Hye-Yeong Kim, Ran Li, Thomas S.C. Ng, Gabriel Courties, Christopher B. Rodell, Mark Prytyskach, Rainer H. Kohler, Mikael J. Pittet, Matthias Nahrendorf, Ralph Weissleder, Miles A. Miller

ACS Nano. 2018 Dec 26; 12(12): 12015–12029. Published online 2018 Dec 11.

Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier

Kenji Yokoi, Diana Chan, Milos Kojic, Miljan Milosevic, David Engler, Rise Matsunami, Tomonori Tanei, Yuki Saito, Mauro Ferrari, Arturas Ziemys

J Control Release. Author manuscript; available in PMC 2016 Nov 10.

Published in final edited form as: J Control Release. 2015 Nov 10; 217: 293–299. Published online 2015 Sep 25.

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

Romeo Ngoune, Christine Contini, Michael M. Hoffmann, Dominik von Elverfeldt, Karl Winkler, Gerhard Pütz

Curr Drug Deliv. 2018 Nov; 15(9): 1261–1270. Published online 2018 Nov.

Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells

Sang-Woo Kim, Yeon Kyung Lee, Sang-Hyun Kim, Jun-Young Park, Dong Un Lee, Jungil Choi, Jeong Hee Hong, Sanghyo Kim, Dongwoo Khang

Sci Rep. 2017; 7: 6454. Published online 2017 Jul 25.

Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment

Kenji Yokoi, Milos Kojic, Miljan Milosevic, Tomonori Tanei, Mauro Ferrari, Arturas Ziemys

Cancer Res. Author manuscript; available in PMC 2015 Aug 15.

Published in final edited form as: Cancer Res. 2014 Aug 15; 74(16): 4239–4246. Published online 2014 May 22.

Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments

Kenji Yokoi, Tomonori Tanei, Biana Godin, Anne L. van de Ven, Masaki Hanibuchi, Aika Matsunoki, Jenolyn Alexander, Mauro Ferrari

Cancer Lett. Author manuscript; available in PMC 2015 Apr 1.

Published in final edited form as: Cancer Lett. 2014 Apr 1; 345(1): 48–55. Published online 2013 Dec 24.